PT - JOURNAL ARTICLE AU - Fernández-Megía, M AU - López-Andujar, R AU - Font-Noguera, I AU - Montero-Hernández, M AU - Puchalt-Escribano, I AU - Poveda-Andrés, J TI - CP-002 Pharmaceutical care system for liver transplant patients using electronic consultation AID - 10.1136/ejhpharm-2015-000639.2 DP - 2015 Mar 01 TA - European Journal of Hospital Pharmacy PG - A1--A1 VI - 22 IP - Suppl 1 4099 - http://ejhp.bmj.com/content/22/Suppl_1/A1.2.short 4100 - http://ejhp.bmj.com/content/22/Suppl_1/A1.2.full SO - Eur J Hosp Pharm2015 Mar 01; 22 AB - Background Information and education for transplant patients can improve their health outcomes. Communication between health professionals through the electronic medical record is used in the management of hospitalised patients.Purpose To evaluate a pharmaceutical care program in liver transplantation patients through electronic consultation.Material and methods Setting: tertiary hospital of 1,000 beds. Design: observational prospective study. Population: 90 liver transplant patients during 2013. System: the physician requests the pharmacist consultation via the electronic medical record. The pharmacist delivers the documentation and training to the patient in collaboration with the medical and nursing team. At discharge, the pharmacist gives education about drugs by an informative newsletter and planning schedule. One week after discharge, he telephones the patient to complete a survey on the training level and satisfaction. Variables: patient characteristics, diagnosis, treatment, level of understanding and satisfaction.Results During the study period, 63 patients met the criteria for inclusion in the system. 100% of the consultations were performed and recorded. (Median; range): 57 years (26–69); 80% male; stay: 14 days (8–60); number of diseases contributing to the patient’s condition: 2.5 (1–9); drugs at admission: 5.5 (0–14); drugs at discharge: 10 (5–10). The main reason for transplantation was viral hepatitis: HCV (58%), HBV (14%), alcoholic cirrhosis (30%) and hepatocellular carcinoma associated with previous cases (14%). 31 surveys were obtained with a level of understanding 4.8 out of 5. 90% of patients used the schedule delivered. 58% claimed to know what it was for each drug, 90% were not confused with taking the medicines and 97% did not forget to take their medicines. Finally, 97% said they were satisfied with the information received.Conclusion The participation of a pharmacist in this system can contribute to a better understanding of the treatments by the transplant patient. Electronic consultation has proved a useful and efficient tool for coordinating activities among professionals involved.Referencess and/or acknowledgements No conflict of interest.